Good morning, ladies, and gentlemen, and welcome to Calian's Fourth Quarter 2022 Conference Call. At this time, all participants have been placed on a listen-only mode, and the floor will be open for questions and comments after the presentation. It is now my pleasure to turn the floor over to your host, Ms. Jennifer McCaughey, Director of Investor Relations. Jennifer, the floor is yours. Thank you, Jenny. Good morning, everyone. Thank you for joining us for Calian's Q4 and Fiscal Year 2022 Earnings Call. Presenting this morning are Kevin Ford, Chief Executive Officer, and Patrick Houston, Chief Financial Officer. As noted on slide two, please be advised that certain information discussed today is forward-looking and subject to important risks and uncertainties. The results predicted in these statements may be materially different from actual results. As a reminder, all amounts are expressed in Canadian dollars except as otherwise specified. With that, let me turn the call over to Kevin. Thank you. Before I begin, I think it's important that I introduce you, Jennifer McCaughey, our new Director of Investor Relations. We're looking forward to having you on board. Jennifer has over 25 years of experience in Investor Relations and will help us to drive our IR program. Welcome, Jennifer. Good morning, everyone. The fourth quarter capped off another record-breaking year for Calian on several fronts. Q4 revenues reached CAD 161 million, up 26% compared to the same period last year. This growth was primarily driven by our expansion in the U.S. and Europe. Gross margin set a new record, reaching over 31%. Similarly, Adjusted EBITDA increased over 50% to reach CAD 19 million, significantly outpacing revenue growth. When I spoke with you last in August, I spoke of supply chain slowdowns affecting near-term revenue. Our teams worked diligently this quarter, and we were able to make significant gains in our ITCS segment in the final months to deliver orders for our customers and recognize revenue earlier than we had previously forecasted. This, coupled with the dedication of our staff, the power of our four-piston engine, and the successful execution of our strategic plans, delivered an outstanding quarter. I would also like to highlight our continued push to win new customers and extend our relationship with existing clients. This quarter, we recorded CAD 161 million in new contract signings, with approximately CAD 100 million from existing customers and the balance from new customer wins. I'd like to turn now to fiscal year 2022 results. I am pleased to report that FY 2022 represents another record year across several key performance metrics as we continued our growth through acquisitions and our journey to bring differentiated solutions that truly add value to our customers. Revenues increased 12% in line with our objective to deliver consistent double-digit growth. In fact, I'm proud to say that this year represents the fifth consecutive year of double-digit growth for Calian. Acquisitive growth this year was very strong, coming in at 19%. Both acquisitions we completed in FY 2022 have exceeded our expectations and helped us diversify both our ITCS and Learning segments. Organic growth took a pause this year, coming in at a -6%, primarily impacted by two factors. The first being the unwinding of the peak COVID response business in our health segment, and the second being our completion of a large ground system project for a North American customer. While organic growth revenue took a pause this year, our five-year trend of driving organic growth has been strong. Patrick will discuss our guidance for next year, where we expect organic growth to return in fiscal 2023. You've heard me frequently say that we are looking to grow profitably across all of our segments. This year, we successfully expanded gross margins and EBITDA margins coupled with our growth. This is our fifth consecutive year we have grown margins at a pace ahead of revenue. I would sum up the year in this way: Our team continued to live our strategy despite COVID or the uncertainty of recent economic impacts. We continue to deliver for our customers, grow into new geographies, diversify our offerings, and reinvest in our business to position Calian to continue the momentum of the last five record years. Our success in FY 2022 can't be told through numbers alone. During the year, we had some leadership announce their retirement as we welcome new talent. Sacha Gera took over as President of the ITS segment, and Michael Muldner started as our CIO, and I would be remiss in not thanking Jerry Johnson, our previous CIO, for his 30 years of service and wish him well in his retirement. We completed two acquisitions which have exceeded all expectations and has again shown our ability to complete successful M&A transactions. We also expanded our service offerings through several initiatives. We launched Nexi, relaunched Corolar to virtual care, added market-leading technologies in the synthetic training, virtual reality, and immersive training, as well as expanded in the space market, designing, developing, manufacturing, delivering ground-based solutions, to name just a few. As we celebrate the company's four-year history this year, let me take a few minutes to demonstrate how far we've come in the last five years. Revenues have almost doubled from CAD 305 million - CAD 582 million, representing a CAGR of 18%. Profitability has paced top line growth. Gross profit more than doubled to CAD 169 million, representing a CAGR of 27%, and gross margins increased from 21% - 29%. EBITDA performance was the strongest ever over the last five years, growing by 164%, representing a CAGR of 27%, and EBITDA margins have grown from 11% or so from 8% - 11%. This performance has been the product of multiple initiatives, but above all, it has come from our entire team bringing their commitment and talent to the work every day to transform our business. Over the same time period, we were able to successfully diversify our revenue streams by geography, customer, and offering. In FY 2022, our revenues outside Canada represented 29% of total revenues, up from 20% in 2018. Revenues from commercial customers surpassed the 50% mark for the first time in our history from 32% just a few years ago. We were able to do this while continuing to grow our legacy Canadian government business. Today, 27% of our revenues are generated from technology products, demonstrating our progressive pivot to a technology company. Each of these milestones is a significant indication of our strategy in action and further motivates us to continue to execute our plan. As we complete the last year of our Imagine 2023 strategic plan, we are focusing on developing a clear path on our journey to become a one billion dollar company, which we're looking forward to share with you. Stay tuned. For now, let me provide an update on the results by business segments. If you've been in one of these calls before, you've heard me mention our four-piston engine and how growth in one segment balances the potential decline in another in any specific order. This diversification allows us to capitalize on opportunities across multiple diverse markets. The broader trend of continued investment in IT and Cyber across North America has helped propel our ITCS group to a record year. The quickly evolving landscape in the global military training market has meant a robust pipeline in our Learning group. These have offset temporary pauses in our Health and areas of our Advanced Tech segments. Both of these segments have promising opportunities starting in fiscal 2023. Let's begin with IT and Cyber. This segment posted impressive revenue growth for both the quarter and the year. Revenues tripled to $69 million in the quarter and more than doubled to $173 million in the year. This growth was driven by expansion in the U.S. market with the acquisition of Computex in March 2022. Their performance has greatly surpassed our expectations. To provide some color on this, we expected to generate about CAD 75 million in annual revenues when we first acquired Computex, but in fact, we generated CAD 71 million in seven months since the acquisition. Our top line growth was also the result of our continued expansion of our Canadian-based cybersecurity offerings and increased demand for managed security platforms. In addition, the easing of supply chain shortages allowed us to deliver a backlog of orders to customers in the quarter. In effect, recording record revenue as we expected to deliver in fiscal half of 2022. In Q4, gross margin increased to 36% and EBITDA tripled to CAD 12 million. In FY 2023, we expect this momentum in our cyber market to continue as we exceed the robust demand in the market and our offerings are well-positioned to deliver value for the customers. Turning to our health segment. The pace of new business in health has not yet picked up to the level where it offsets the last remnants of the impact of COVID-19, resulting in a decline of revenue quarter-over-quarter. We've continued to focus on service delivery and building up a network of healthcare practitioners across Canada in what has been a very challenging backdrop coming off two years of COVID fatigue. While revenues for Q4 declined 11% to CAD 39 million from CAD 44 million from the same period last year, gross margins and EBITDA margins held steady at 25% and 16% respectively, a testament to our proactive management of costs. In fiscal 2023, we expect a return to organic growth. Despite the reduction in revenue this year, we remain optimistic about our market position and our three-pronged approach to drive future growth, including digital health technologies, pharmaceutical solutions, and health solutions and services. In fact, after quarter end, we won a contract with the Provincial Health Services Authority of British Columbia to provide hospital nursing services support across all five health authorities. Turning to our Advanced Technology segment. As we near the completion of our largest ground system project, which has impacted revenue growth, our diversity into adjacent markets has begun to yield results. These lower volume but higher margin divisions has resulted in gross margin and EBITDA margins increasing significantly to 33% and 15% respectively. Currently, we are seeing strong demand in our software engineering for satellite and communication customers, as well as demand for our precision location services through our GNSS products. Looking to FY 2023, we expect to return to organic growth. The diversification I mentioned in our space and terrestrial division over the past several years is going to help us offset what was a slower second half for awards of new large ground system projects. We've already seen some breakthroughs with the announcements of a new CAD 12 million project for the three new Earth observation antennas. Turning to our learning segment. In Q4, revenues increased 24% from the previous year, coming in at CAD 22 million. Similarly, for the year, revenues increased 23% to CAD 92 million, up from CAD 75 million from last year. This growth was driven by the acquisition of SimFront at the start of the year, which allowed us to expand our Canadian military training presence, as well as expand it into the U.K. They've also brought technologies that are relevant to commercial customers, we have continued to develop a pipeline of opportunities. In Q4, gross margins were down slightly from previous quarters due to the timing of software and projects. For the year, gross margins and EBITDA margins increased to 25% and 18% respectively versus 23% and 17% in the prior year. In fiscal 2023, we see continued demand for our services and technology in the military training space in Canada and Europe, this should put us on track to break the CAD 100 million revenue mark for the first time in our learning segment. Now, I will turn the call over to Patrick to discuss cash flow, balance sheet, and our guidance outlook for fiscal 2023. Over to you, Patrick. Thank you, Kevin. Driven by significantly higher EBITDA, profitability increased. Net profit in FY 2022 increased to $14 million or $1.19 per share, up from $11 million or $1.07 per share for the same period last year. The significant increase in profitability was offset by increased charges as our acquisitions have outperformed and achieved their earn-out targets. The amortization of intangibles for current acquisitions is tapering off and will result in further net earnings in coming periods. Adjusted net profit, which isolates the one-time impact of acquisition-related charges, grew 19% to $44 million, or $3.87 per share, up from $37 million or $3.50 per share last year. Through execution and accretive M&A transactions, we've been able to grow this by 150% in the last five years. This continued strong profitability translated into robust cash flow generation and has become a staple of our operating efficiency. While posting record EBITDA margins and growing this at a pace significantly above our top-line growth, our conversion to cash flow has consistently improved as we have gained greater scale and have been able to implement further operating efficiencies. We generated operating free cash flows of CAD 47 million this year. This is up 38% from last year and up 213% in the last five years. During those five years, we've increased our cash flow conversion from 50% to above 70% in this most recent year. This strong conversion and focus on managing working capital in the longer term means that our already strong liquidity position will strengthen in the coming periods, allowing us to continue to invest in our M&A agenda. We continue to have a disciplined approach to capital deployment in FY 2022. When we say discipline, we mean consistent deployment of capital with the view of getting maximum return for the amounts invested. As Kevin mentioned earlier, the early returns from our last two acquisitions have been strong. Their performance has been above expectations, both will be key contributors in fiscal 2023. We've continued to pay earn-outs as they're earned, again, showing that the acquisitions we've made are growing and consistently hitting or exceeding their targets. We've maintained our dividend rate at CAD 1.12 per share. We continue to see the dividend as an important part of our balanced capital deployment strategy, we'll reevaluate the size of the dividend in future quarters. Our CapEx levels have remained stable despite significant increase in the size of our business over the last five years. This again speaks to our improved operating cash flow efficiency. We continue to invest in capital that will help us scale and not inhibit our growth aspirations. After making all these investments, we ended the year with a solid balance sheet. As of September 30th, we are in a net cash position once again. Our cash on hand of CAD 43 million, combined with our unused credit facility, provides us with CAD 150 million of net liquidity. We are able to further expand this liquidity with our current lending syndicate if need be. This strong balance sheet position, coupled with strong profitability and cash flow conversion, positions us well in a more uncertain market and will help us continue to execute our strategic plans. In addition, we're starting a new year in a position of strength. We signed an additional CAD 699 million in new contracts in FY 2022, of which over CAD 400 million were contract renewals and extensions. We also exited the year with a robust backlog of CAD 1.3 billion, of which over CAD 400 million is planned to be realized in fiscal 2023. As we seek out new customers and new geographies, this strong backlog of business will serve as our anchor as we look forward to another year of record growth. Let's take a look at our guidance for FY 2023. For the fiscal year ended September 30th, 2023, we expect revenues in a range of CAD 630 million-CAD 680 million. At the midpoint, this reflects revenue growth of 13%, and this would represent our sixth consecutive year of double-digit growth and record levels once again. It also assumes a return to positive organic growth with an even split between organic and acquisitive growth from the full year impact of acquisitions completed midway through last year. We expect Adjusted EBITDA in the range of CAD 70 million-CAD 75 million. At the midpoint, it reflects Adjusted EBITDA growth of 10%. This growth takes into account the current economic conditions, cost increases, and continued impact on supply chains. Finally, we expect adjusted net income in the range of CAD 46 million-CAD 50 million for the upcoming year. Our strong Q4 performance and ability to accelerate revenue will mean that our first half of fiscal 2023 will be slightly lower weighted than the second half of the year as new business comes online fully. Finally, I must caution that revenues and profitability realized are ultimately dependent on the extent and timing of future contract awards, customer realization of existing contract vehicles, and any impacts due to COVID-19. Our guidance does not incorporate any additional M&A activity. Should we close any new opportunities, their contributions would be incremental. Please see our press release in MD&A for detailed reconciliation of our guidance. Now I'll turn the call back over to Kevin to conclude our prepared remarks. Thank you, Patrick. In conclusion, we had a record year yet again as our four-piston engine continues to deliver on a consolidated level. What's more, coming off a record year, we are on track to sustain this pace and deliver another record year while continuing to search for strategic acquisitions. I wanna thank our staff for their commitment and dedication as they make all the difference in our results. I'd also like to thank our customers for their loyalty, our suppliers for their collaboration, and our shareholders for the continued support. We are also proud to announce the publication of our inaugural ESG report. It describes our journey as we work towards embedding ESG best practices into our business. We developed a strategic framework to build, set priorities, and drive value for our shareholders and stakeholders. You can find the report on our website. With that, Jenny, I'd like to now open the call to questions. Thank you very much. Ladies, and gentlemen, the floor is now open for questions. If you have any questions or comments, please press star one on your phone at this time. We ask that while posing your question, you please pick up your handset if you're listening on a speakerphone to provide optimum sound quality. Please hold while we poll for questions. Thank you. Your first question is coming from Amir Ezzat of Echelon. Amir, your line is live. Kevin, Patrick, good morning, and congrats. Can you speak to the quarter-on-quarter growth in IT and cyber? There's an incremental CAD 20 million in revenues, which is pleasantly surprising. Is that concentrated to one specific project or customer? Or how do we think about that? Good morning, Amir. Yeah, it was a tremendous quarter for the IT/TS group. Part of it was dealing with some of the backlog that we had built up over the last couple of quarters. A lot of it started to come into focus here in the last quarter. We were able to deliver it. It wasn't one specific product, but just clearing out some of the backlog across multiple of our customers in several different industries. It was strong performance from our team to make that happen given, you know, the current challenges on the supply chain. Okay. What do you feel is a normalized, like revenue levels like for IT? I assume it's not like the CAD 68 million or CAD 69 million you guys reported. Certainly, we did see a significant bump from that. I think, we get back to a more, you know, somewhere between the Q3 and Q4 performance going into next year. We're still feeling a lot of momentum on our IT business. Certainly they're white-hot right now, so I think they're gonna continue that momentum into next year. Fantastic. Can you give us a little color on the pace of new projects starting in Advanced Tech? I mean, you guys recently announced the Natural Resources Canada contracts. You've got the European project as well. I'm trying to get a sense if you feel that Q4 was a trough quarter for Advanced Tech, essentially? Yeah. Thanks, Amir. It's Kevin. For Advanced Tech, it's important to look at all the moving parts between our space, terrestrial, and defense business. From our legacy space business right now, with the announcement of the three antennas, we had announced earlier, a NASA antenna with regard to our InterTronic team in Montreal. Our GNSS products, our global positioning of precision location antenna business is actually growing significantly year-over-year. Right now, I'm expecting Advanced Tech actually to make a turnaround this year from a growth posture. We see good backlog, we see good opportunities. When you look at, you know, our aerospace and defense element, as well as our terrestrial element with our IntraGrain, we're seeing good push across each of the divisions within that business unit. Right now, I'm expecting a good year from Advanced Tech and right now coming out strong with a few key wins to kind of propel that growth for next year. Definitely Advanced Tech is on the comeback this year and across a bunch of setting of projects that, you know, I'll talk about our Investor Day later, but we're definitely gonna give this more exposure to our shareholders with regard to all the exciting things happening at Advanced Tech right now. Fantastic. Kevin, like, your stock price has held up well in the face of very weak-ish markets, and you guys remain pretty under levered. Can you maybe give us an update on your appetite for M&A, and how would you characterize, like, the current markets? Are you guys seeing a lot of attractive opportunities or what's happening? Yeah, we've continued to see good momentum on M&A side. We're still quite busy looking at a lot of targets, and working with some key opportunities. You know, the pace that we've set here in the last couple of years of doing, you know, one or two strong deals that have really performed, I think is our objective here going into next year. That's what I continue. We certainly have the balance sheet to execute those deals. I think we're well-positioned as long as, you know, things come into focus, to have another good year from an M&A perspective. Maybe one last one, Patrick, on the working capital side, anything to read, any jump in accounts receivable? What is driving that? I mean, we really pushed hard to finish the year strong. We did deploy some extra cash towards the working capital to make sure some of the material came in so that we could realize the revenue. I think a lot of that is very, very short term and should kind of reverse back out in the next couple of quarters. I wouldn't be overly concerned, and I think it was the right thing to do to make sure we're well-positioned to have the equipment and parts we need to deliver revenue in Q4 and into next year. Great. Thanks. Congrats on a strong quarter. I'll pass the line. Thanks, Amir. Thank you very much. Your next question is coming from Doug Taylor of Canaccord Genuity. Doug, your line is live. Yeah, thank you. Good morning, Kevin, Patrick, and congrats on a very robust finish to the year. Thank you. I wanted to ask a couple of questions about the health unit and what's implied in your guidance. I mean, obviously last year there was some volatility related to, you know, COVID work. Can you speak to what degree you factored, I guess I'd call it, you know, any temporary or short-term work, into your guidance for the health unit in the year ahead? Yeah, thanks, Doug. It's Kevin. We've really not factored in any additional, you know, COVID-19 or, you know, immunization work that really dominated the last, you know, frankly, couple years in our health business unit. We have in fact added in a lot of our work right now is getting back to what I call business as usual with regard to healthcare services. As I mentioned, the product launch we're doing now, focusing on that, our pharma business contract research, patient support programs. We're kind of getting back to what I consider to be a normal healthcare business. Right now nothing's factored in that that would be aligned to COVID-19. Okay. I see from your disclosure you talked about some temporary slowdown due to some contract transitions. Can you shed a little bit more light on this and when you might expect those to be resolved? Yeah. Our pharma business certainly runs kind of on a cycle where we get projects, we work on them for a couple years, deliver, and then usually the customer comes on with an additional project. We did see some gap there in Q4 where some of the projects were winding down and we hadn't started the new ones. We have a strong pipeline on the pharma side for FY 2023, and we think it was just more of a timing issue than a slowdown in the business. Okay. Nothing related to your kind of foundational contracts supporting, you know, military and things like that, in the health unit or are there any of those upcoming that we should be aware of? No. They've continued strong demand from that strong base of customers we've built over the last five years, like 50 contracts across Canada. Those have continued. Our biggest struggle has been finding the resources. You know, healthcare workers in general have been, you know, very tired after COVID-19 and that's probably our biggest challenge right now. The demand from the customer side continues to be strong. Okay. Maybe last question from me. I mean, in your IT and Cyber, you're talking about relief from supply chain previous supply chain issues. You also speak, on the other hand, to some part shortages in your Advanced Tech unit. Is there visibility to relief on those, if it is supply chain impacted as well as we've started to hear from other hardware vendors that, you know, most of that's loosening up? Yeah. We've gotten some promising feedback here in the last couple of months that, you know, we've seen kind of lead times actually reduce from, you know, what we were getting lead times that were more than a year on certain parts, you know, come down. That would point to, you know, things getting better here in the next three to six months. You know, again, it's a bit of a waiting game to see if that actually comes true. Some of the information we've gotten seems to indicate, you know, better 2023 than 2022. Doug, what I didn't mention before because the question from remember on the Advanced Tech group, you know, we do have a backlog of products that are sold, again, waiting for parts. We think that will relieve, you know, first quarter, second quarter for sure. I'm hoping by this time next year we're not talking about this anymore, Doug. In the same spirit, a lot of opportunity, and I think again with backlog and parts, we're gonna see that unwind in Q1, Q2 in Advanced Tech. Still very optimistic on that based on my discussion with Pat, who runs that. Hopefully we see that actually happen over the next quarter here. I hope we're not talking about it anymore as well. Thanks. Yeah. Yeah. I'm sure you're asking, I'm sure you're tired of asking the question. Thank you very much. Your next question. Thanks, Doug. is coming from Benoit Poirier of Desjardins Capital Markets. Benoit, your line is live. Yeah. Thank you very much. Good morning, Patrick. Good morning, Kevin. Morning, Benoit. Yeah. Just to come back on Advanced Tech, you made great comment about the expectation of positive organic growth going into fiscal 2023. Just in terms of margin profile, could you maybe provide some color given the completion of the large ground system contract and positive organic growth assumption, whether we could see further upside in terms of EBITDA margin specifically for Advanced Tech? Yeah. Thanks, Benoit. Yeah. I think you start to see some of that this quarter, as the mix kind of went away from the large ground system business to some of the adjacent markets Kevin spoke to that we've been, you know, working hard to expand into. You saw the margins kind of tick up this quarter. I think right now it's, you know, in the near term, you know, maintain those margins and hopefully by the end of the year we're improving it back to kind of historical levels for AT, just as the mix gets better. I think that there's some room to grow there. Okay, perfect. On the learning side, there was a good mix of organic growth contribution from the latest acquisition, although margins came down sequentially. If you could provide more color about what could explain the drop from the 18%, what could be the reason behind the drop and also kind of a reasonable assumption we should be looking for for fiscal year 2023? Yeah. I think, as we've pivoted, you know, what was historically a very service-oriented business to more technology, we've seen, you know, the better margins, but that also brings a bit of, you know, variability depending on software sales and deliveries, which are generally much higher margin. I think that was the reason for the Q4 change. I would look at the level for this entire year, Benoit, as kind of a guidance on what we can deliver next year in learning. Okay. Okay. That's great. For ITCS, obviously you talked about the strong contribution in the quarter and kind of some expectation going into next year. It seems that you've been very good at leveraging the Computex acquisition. Just wondering about the opportunities to leverage that pass up in the U.S. Any opportunities there or any... Yeah. Yeah. Thanks, Benoit. I think from our viewpoint, you know, the acquisition, and Sacha is, and the team have been doing a great job in both not only integrating Computex into the Calian family, but really remaining focused on our customers. You know, having actually visited their sales kickoff this year, it's probably one of the most mature sales engines we've had in Calian. It's pretty incredible. Now with presence in Houston, Florida, Minnesota area, we see great customer demand as organizations look to pivot with regard to their cyber infrastructure managed services. The team is now driving more recurring revenue as well through that segment, so we're seeing those opportunities as in between our security operation centers that we now have now in Houston and Toronto. From my viewpoint, we continue to see great demand in network services, cyber services, our product relationships with organizations like Cisco. We do believe that frankly, that momentum is gonna continue. For going forward, we wanna combine that organic growth engine that we acquired through Computex and iSecurity, as you remember, Benoit, about one year ago, two years ago, and also look for other M&A opportunities to continue to expand our footprint in the U.S. We expect ITCS to remain white-hot into the year, and it's definitely got our focus as we see that segment as definitely a high margin, high growth opportunity. Okay. In terms of working cap, Patrick, you mentioned color about Q4. What should we be looking at for fiscal 2023, given you're still growing, but you mentioned that there could be some release in the shorter term? Should we expect still some consumption of working cap given the growth posture ahead of Calian, ahead of you? I think our target is to be neutral to slightly positive. We've got some things coming back to us this year between the investments we made in Q4 and some of the ground system project unwinding. That'll be offset by some of the growth that we're forecasting, obviously, you know, +10% growth again next year. Our target is to be, you know, neutral to slightly positive, and hopefully some positive info here in the first half of the year. That's great color. Just in terms of tax rate, was there something unusual in the quarter that could explain maybe a higher income tax? When we look at the compensation and change in fair value related to contingent earn-out, it total about CAD 10 million in fiscal 2022. From a modeling standpoint, I'm just wondering how should we be looking at this, those two items, going into fiscal year 2023. If you could provide some color about the tax rate, that would be great. Sure. On the deem comp and the earn-outs, like we've, you know, we've continued to see over-achievement from several of our transactions, you know, Tallysman, iSecurity, and Dapasoft, SimFront. We've booked pretty much all of the earn-outs now, so I'm not expecting any large changes on that going into next year. On the tax rate, yeah, I mean, the net income was significantly impacted by that, so it made the tax rate look unusually higher. On a cash basis and against EBITDA, I think it's stable to the last periods. You know, we're still kind of on a cash tax in that, you know, 23%-25%. That's what I expect for next year. Great color. Thank you very much for the time. Thanks, Benoit. Thank you. Thank you. Your next question is coming from Maxim Matushansky from RBC Capital Markets. Maxim, your line is live. Thank you, good morning. I just wanted to circle back on Advanced Technologies and I guess how much, you know, how much of what you've been talking about is for next year is waiting for parts, and how much of it is kind of the slowdown in the contract award timing. I'm just trying to wonder how much risk there is for some of those awards to slip later in the fiscal year or if it's primarily the supply chain issues that you have more visibility on. I would say right now, from a supply chain perspective, it's affecting certain elements of our products. We've been able to maneuver through that on our GNSS antennas. We're not expecting a slowdown. We expect to see continued growth in our precision antennas. It's specifically some of our products, our Decimator products, where we're waiting. We have a backlog of orders, and we're just waiting for specific parts to move that. It's not significant in the context of revenue, I'd say, but definitely in margin, it's gonna help with the Advanced Tech performance. As far as the pace of business, again, with some wins in our belt here now and some good opportunities that we're right in the middle of the bid process. These aren't bids we're waiting for. We're right in the middle of the, you know, going through the evaluations. We expect, you know, the next, you know, quarter, we'll be hearing wins or losses. We still have quite a few opportunities in the funnel. We're feeling pretty good about the organic growth, as I mentioned earlier, in Advanced Tech, Maxim, because of the backlog in parts or backlog, sorry, in products, as well as just the bidding pipeline right now in our ground system business, our GNSS antenna business, our integrating business. Our nuclear business is going well. We're having some good opportunities also in defense manufacturing. Again, I expect this to be a turnaround year for Advanced Tech and a growth posture across many, many factors that are gonna give us some tailwinds this year. Got it. Switching to the learning segment, I mean, there's been continued rhetoric about military spending in light of the conflict in Ukraine. I'm just wondering if you're seeing any immediate impact from that on demand for Calian's business, or we should think about that as more of a longer-term tailwind? Great question. It's really gonna be both short and long term, I believe. What we're seeing in the short term with our customers in both Canada and now NATO and Europe is an increased demand for training across multiple disciplines. Exercise rehearsal, cyber, so you're starting to see more cyber requests. In the short term, it's definitely gonna give us some opportunity. And I think, you know, we built that into our guidance for next year from our learning segment. As I mentioned, we're pretty excited by, we see the potential of our learning business being over CAD 100 million next year. On longer term, the defense spending, the way this works is that that money sometimes takes time to get from budget into program. We expect longer term as well, that this will be a positive tailwind for Calian across all of our businesses, whether it's on recapitalizing equipment, increasing the training capacity and pace, the IT cyber spends. We see both short and long term, this is an opportunity, Maxim, and definitely for our learning business, increased demand and training pace, I would say, both in Canada and Europe. Great. Finally, just on M&A. I know you mentioned, you know, looking at kind of the bigger deals. Are there any segment that looks more attractive in the near term given kind of the changes in the macroeconomic conditions and movements of valuations? Are you seeing any particular segment that looks attractive either from a valuation perspective or from a, you know, Calian strategy perspective? ITCS still is a focus for us just because of, you know, we've purchased a couple of good assets there that have really been performing. We're looking. We've got a strong team there, so we're saying how can we supplement that with additional assets that would give us either, you know, geographical reach or more net new talent, which is an issue in this space right now. Health's come back to us where I think the valuations were too high for us the last couple of years. That's come back, so I think that's helped and continue to see some good targets in both AT and learning. I'd say right now, all four of them are pretty active from a pipeline perspective, with ITCS and being one of the our main focuses here for FY 2023. Yeah. Maxim, it's Kevin. I think for me, the opportunity we have is that diversity again. As Patrick mentioned, we have discussions going on in each of our segments. I can confirm that. Each of our segments right now is out with active discussions around M&A. Aligned to our strategy. You know, we wanna make sure that when we're doing acquisitions, it's supporting our strategy as well as our goals to increase, you know, margin and differentiation as well as diversification. All of our segments have opportunities, but we do take time, and we make sure we're very, you know, rigid on our due diligence. The pace of these will be really at the pace that we're comfortable that we found the right targets and the right ones that are gonna support our strategy. I would expect this year across each of our segments, hopefully some activity, but we're not pushing it until we make sure we have the right type of company that will fit into Calian long term. Great. Thanks. I'll pass the line. Thanks, Maxim. Thank you very much. Your next question is coming from Deepak Kaushal from Stifel Capital Markets. Deepak, your line is live. Hi. Yeah. Just a quick correction. It's BMO Capital Markets now. Good to talk again, Kevin and Patrick, and nice to have you on the call, Jennifer. I have a couple follow-ups here I think I can fit some in. Just on the Advanced Technology, you know, you mentioned a couple of orders that came through, one for NASA and one for, I think, it's Natural Resources Canada, ground systems and antennas. Can you talk about what's particularly moving those forward given the delays recently? Is it, is it certainty on interest rates, or is it project-specific factors here? What can we read through across the broader segment of that space side of it and technology business? Yeah. Hi. Good morning, Deepak. Definitely to your point, you know, we've seen some delays in new satellite launches. Some of the new LEO constellations are working through that, either looking at their debt posture. We're seeing that definitely create some delays. The ones that we've signed were basically on the books and moving forward with regards to customers that had, you know, their funding and had a requirement short term to get new observation data or a deep space exploration. What we're seeing right now is still a good pipeline, frankly, of ground-based antenna opportunities. With our acquisition of SatService and InterTronic, we also have the ability now to expand our antenna line with regard to the size and complexity of the antennas we build. In the past, there were larger aperture antennas. Now we can do things, and we've done a bunch of research and development with a carbon fiber 4 m antenna, full motion 4 m antenna, which is relevant for LEO constellations. In some ways, these delays have been good for us 'cause it's allowed us to pick up our R&D and our product lines to be responsive to these as they come to market. We have some good short-term opportunities and actually really excited about long term 'cause our product, you know, if you walked into the Calian restaurant of antennas, our menu is much fuller with regards to both capacity size, right from GNSS to now, you know, 15 m antennas, whether in metal or carbon fiber. We expect this to continue to be a strong push for us, Deepak, in the next few years for sure. Okay, great. Just a couple clarification questions first on the M&A and then on the cash flow. On the M&A side, you know, initially it kinda sounded like you guys were focusing on two segments, or two big acquisitions and two big good acquisitions, one particularly being ITCS, and then more recently you said you're looking for activity in all four. I mean, how do you decide which segment to feed? Can you feed all four segments in the next 12 months? Just maybe just in general, like your capital allocation process and how you think about, you know, Capital allocation across your portfolio of businesses, if that makes sense as a question? Yeah, no, it's a great question, I think. Frankly, you know, as you look at the four segments, you know, I wanna reiterate a few things. Number one is that we have, you know, our strategic plans and business plans in place, and we look to identify in those plans where we wanna grow something either organically through R&D or new innovation, that's one of the reasons I created a CTO position here, or it's gonna be an M&A opportunity. Across our strategy, M&A, as a reminder, supports either diversification, innovation or both. From a capital allocation perspective, working with the business unit presidents, working with Patrick, who I've asked to run our M&A office, you know, some of these things, the timing of them can be offset. You know, we never really see something just align where we have four acquisitions in one quarter or just the way these things play out. We're actually proactively monitoring. It's almost a daily discussion with Patrick, I, our M&A team, our business unit presidents on the status of these discussions. From a capital allocation perspective right now, we are really looking to prioritize high margin, high growth, high scale opportunities across each of our segments, Deepak. We will definitely, you know... We'll keep that M&A engine running. Patrick, any comments you'd like to make on capital allocation or our M&A pipeline? Yeah. I think you're bang on. We keep looking at all four. The timing on these is always uncertain, so it gives us some optionality. On the size, again, as we've gotten bigger, I think we're focusing in on those acquisitions that can really have an impact both strategically and financially across each of the four segments. I think that's what you're gonna see from us in the short to medium term. Okay. That's fantastic. Just lastly on working capital. You know, Patrick, you mentioned earlier on the operating cash flow, you're converting now 50%... Sorry, 70% up from 50%. Yeah. You know, given the growth expectations for this year, you're expecting to be working capital neutral. How should we think of that going forward? As you grow the businesses, the working capital requirement, certainly in some of the large projects, there's a big working capital requirement. Can you continue to grow the business at double digits and maintain working capital neutral here, or is there some kind of cash investment required there that we're missing here? I think it depends as the business goes. I think for next year, certainly, you know, we're looking for double-digit growth. We've got some working capital we're trying to pull back in that's gonna kinda offset that growth. That's why I'm thinking we can be neutral to net up next year. And, you know, going forward, we're just being, you know, from a conversion perspective, as we scaled and gotten much bigger, we've gotten more efficient, both from a CapEx, a tax perspective, which has really allowed us to convert that EBITDA into cash flow. I think that's maybe a misunderstood thing about Calian, but I think it's certainly a highlight in this market today and our ability to convert that kind of operating performance into real cash flow for the business. Okay. That's helpful. Thanks. Well, look, I'll leave it at that and appreciate you taking my questions. Thanks, Deepak. Appreciate it. Thanks, everyone for the questions. They're excellent. Thank you. Your next question is coming from Nick Agostino of Laurentian Bank Securities. Nick, your line is live. Yes, thank you and good morning, everybody. I just wanna understand, Kevin, on the M&A front now that you've put, you've got the CTO position in place and all that, how do you guys approach M&A? Do you just, you know, look at targets that are out there and take more of a business economics view and look at targets that give you good growth potential, maybe open up some market segments and give you some good economics? Or do you take as part of that decision, product base? In other words, you're looking at your current offerings, maybe identify some product gaps based on customer feedback and make that internal decision to either acquire or build. Just trying to understand how you guys are approaching M&A. Is there a product gap approach to it? If there is, what are the product gaps that you have identified within the four segments? Yeah. Great. Thanks, Nick. From an M&A perspective, it really does support, as I mentioned, that, you know, our customer diversification and innovation. I'll take Computex as a great example of that. In one acquisition, you know, we were able to diversify our customer base to know government. It was all private industry, SMB, or sorry, mid-market, you know, customers over 1,100 new logos. Massive tick mark on our customer diversification objectives. You look at the innovation that that acquisition brought with regard to the relationships with organizations like Cisco and CrowdStrike, and then as well, our managed security services, now with iSecurity. When I look at the acquisitions going forward, we wanna do the same type of thing. We wanna find those acquisitions that bring us more diversification in our customer base, whether it's in certain sectors, whether domestically, whether globally. Also, as you said, in product gap, look at more innovation. Buying organizations that are bringing some element of technology, some element of differentiation through their products to help augment our current product/services mix. It's a bit of all of it, to be honest with you, Nick, with regard to, our approach here. We match that strategy alignment with the financial metrics that we look for, both in past performance and future performance. Then we spend quite a bit of time with the organizations to assess culture fit, 'cause we do believe that's a key element of these as well. It's a bunch of moving parts in M&A at Calian, but I'm, I... We learn from everyone. You know, there's nobody perfect in M&A, but we're learning from everyone. From my viewpoint, though, that innovation, customer diversification across all that we do is gonna be the main focus for M&A engine across each of our segments. Hopefully I answered your question there. I rambled on there a bit, but hopefully I answered your question. Yeah, no, that was helpful. I guess just as a part B to that, you mentioned product innovations. When you look at your current offerings, are there any product innovations or ideas that maybe you think you need to add and you may be contemplating building or at the same time you're out there looking to acquire if the opportunity is there. Is there anything that you have identified from a product gap or is it just you look at the M&A targets that are in front of you and you evaluate what innovation they might have as opposed to having something in mind? Well, I think for us, you know, just at a high level, if you kinda walk through our segments. In our health business, clearly, as you look at our Nexi and Corolar virtual care platforms, this year we ran through L-SPARK here in Canada with Gordon and Sacha. We ran an opportunity to look at products that could build into our current product base, we're referring to as ecosystem development. I would say, you know, at our healthcare platforms, we'd be looking for pieces that could help augment that platform and basically continue to differentiate it and provide more value to customers. In our learning space, our SimFront, SimWave acquisition has been very, an eye-opener for us and just on the amount of innovation and learning across virtual reality, wargaming, the things that are now being asked for by customers. Again, more opportunities to expand our learning portfolio to make that training environment as real as possible, and an immersive learning/virtual reality capability would be one. If you look at our Advanced Technologies Group, you know, continued expansion of our space business is gonna be an important element of this 'cause we do believe long-term that this is gonna continue to, you know, be a massive growth opportunity for us to support our growth objectives. We're looking at, you know, diversification of our antenna, our capability, recurring revenue opportunities. Then on our IT segments, again, we have got now quite a bit of, as Sacha was telling me, quite a bit of technology on the truck and we are looking to amalgamate, integrate those technology components, but in the same context, look to invest in new capability to strengthen our cyber resilience offerings, as well as building more ecosystems out there regarding products that could plug into our cyber services. It's, believe me, there's a lot of discussions here that we have across each of those segments. That's just to highlight a few and, you know, I could probably spend 15, 20 minutes on this alone, just on each of our segments as to all the different moving parts. Those are kind of the highlights and priority for the time. Okay. No, I appreciate that. I guess just one last one. I think you kind of highlighted the pretty strong demand or interest on the augmented reality. Can you just talk to how, I guess, the cross-sell that you're getting when it comes to your digital assets on the healthcare side, what the reception has been in the marketplace, the cross-sell, and more importantly, maybe specifically, what the growth rate is for those particular products? I'll leave it there. Yeah. I think for me, you know, as we launch digital products and I expect, you know, my expectation here in the company is everything's a double-digit growth number. I wanna see that. As you look at those product launches in Corolar and virtual care, our Nexi platforms. There's a lot of presentations right now. It's as you integrate new products and introduce new products to the market, it takes time. We're expecting this year not to see massive growth there. We expect to be investing on getting product understanding, product awareness and working with customers. We're doing lots of work now. We're adding extra sales capacity in the U.S. to actually get these products to market. The point you made, you know, I don't talk about enough, frankly. When you think about the convergence opportunities across our business units, we're definitely seeing more of those. You know, we're looking at remote healthcare. We just recently did an opportunity where we combined our healthcare business with our satellite business to basically provide a remote healthcare unit that then has a remote learning capability and a cybersecurity element to it. We're starting to see those opportunities that come across our business units in what we call convergence opportunities. Stand by for those. Each one of the segments right now, we're gonna have more innovation, more product gaps, as you said, things that we're fixing. As importantly, we're looking for those opportunities to move across the business for collaboration with our business units for customers' biggest challenges. Okay. Thank you for that. Thank you so much. Last one. Thanks. Thanks, Nick. Okay, we don't appear to have any further questions in the queue. I'm now gonna hand back over to Kevin for any closing remarks. Okay. Thank you, Jenny. For facilitating today's call. Before we close, I'd like to mention that we will be hosting an investor day in Toronto on February 15th. Please save that date and more details will follow in the next couple of weeks. On that note, I wanna thank everyone for attending, and I wanna thank everyone for the great questions, and we look forward to providing an update on our next quarterly call. With that, Jenny, we can close the call. Thank you very much. Thank you, ladies, and gentlemen. This does conclude today's conference call. You may disconnect your phone lines at this time and have a wonderful day. Thank you for your participation, and have a great weekend.